InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
3
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by McAvoy David R., Conseiller Juridique et Directeur de la Conformité. Insider active across 4 companies, notably Brickell Biotech, Inc.. Cumulatively, 5 disclosures have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €41k. Activity tracked since 17 May 2021. The latest transaction was filed on 5 September 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to McAvoy David R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
1,113 股@ US$18.8572100.0% 占其流量Ordinary SharesSEC:0000950170-25-113800:0
标准退出：2025年12月4日 (T+90)
16,741 股Ordinary SharesSEC:0000950170-25-034670:0
20,000 股Common StockSEC:0001628280-23-033914:0
18,124 股@ US$0.669745.7% 占其流量Common StockSEC:0000819050-21-000124:0
标准退出：2021年10月21日 (T+90)
18,622 股@ US$0.8054.3% 占其流量Common StockSEC:0001062993-21-004867:0
标准退出：2021年8月15日 (T+90)
5 条申报中的 5 条
About McAvoy David R.
David R. McAvoy is General Counsel and Chief Compliance Officer at Brickell Biotech, Inc., a company specializing in the development of biopharmaceutical therapies. In this role, he is responsible for legal and compliance matters, ensuring that the company adheres to applicable regulations.
